Fennec Pharmaceuticals (FENC) Free Cash Flow Growth (5y) (2015 - 2025)
Fennec Pharmaceuticals (FENC) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.67% |
| Sep 30, 2025 | 17.86% |
| Jun 30, 2025 | -3.42% |
| Mar 31, 2025 | -2.87% |
| Dec 31, 2024 | 1.50% |
| Sep 30, 2024 | 0.26% |
| Jun 30, 2024 | -24.93% |
| Mar 31, 2024 | 76.34% |
| Dec 31, 2023 | -10.65% |
| Sep 30, 2023 | -11.54% |
| Jun 30, 2023 | -20.24% |
| Mar 31, 2023 | -26.42% |
| Dec 31, 2022 | -38.81% |
| Sep 30, 2022 | -39.22% |
| Jun 30, 2022 | -37.57% |
| Mar 31, 2022 | -33.44% |
| Dec 31, 2021 | -39.65% |
| Sep 30, 2021 | -40.31% |
| Jun 30, 2021 | -56.60% |
| Mar 31, 2021 | -48.41% |